| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |